Morphine Sulfate Injection · #6 of 35 active shortages by FDA posting duration
Brand: MITIGO
FDA lists Morphine Sulfate Injection as Active Shortage (Piramal Critical Care Inc.).
Availability on file: Available
Morphine Sulfate Injection: Active Shortage
Available 27 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Morphine Sulfate Injection
- Manufacturer
- Piramal Critical Care Inc.
- Dosage Form
- Injection
- Presentation
- Mitigo, Injection, 500 mg/20 mL (NDC 66794-162-02)
- Package NDC
- 66794-162-02
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Oct 31, 2017
- Last Updated
- Dec 18, 2025
- Therapeutic Category
- Analgesia/Addiction
Row fields from the FDA Drug Shortages database via openFDA.
Full Drug Profile
morphine
Side effects, interactions, warnings & more
Nearby, Other Morphine Shortage Records
Morphine Sulfate Injection
Piramal Critical Care Inc.
Injection
Morphine Sulfate Injection
Fresenius Kabi USA, LLC
Injection
Morphine Sulfate Injection
Fresenius Kabi USA, LLC
Injection
Morphine Sulfate Injection
Hospira, Inc., a Pfizer Company
Injection
Morphine Sulfate Injection
Hospira, Inc., a Pfizer Company
Injection
Morphine Sulfate Injection
Hospira, Inc., a Pfizer Company
Injection